Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H van Vliet

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Netherlands Journal of Medicine|January 1, 1984
Hereditary antithrombin III deficiency and venous thrombosisJ J Michiels, H H Van Vliet
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Acquired von Willebrand disease in monoclonal gammapathies: effectiveness of high-dose intravenous gamma globulinJ J Michiels, H H van Vliet
Scandinavian Journal of Haematology|February 1, 1984
IgM and IgG platelet antibodies in a case of infectious mononucleosis and severe thrombocytopeniaM C Kappers-Klunne, H H van Vliet
Transfusion|October 26, 1999
Coagulation factor levels in solvent/detergent-treated plasmaF W Leebeek, M R Schipperus, H H van Vliet
Atherosclerosis|August 1, 1990
Coffee, caffeine and hemostasis: results from two randomized studiesA A Bak, H H van Vliet, D E Grobbee
British Journal of Haematology|March 1, 1986
Pseudothrombocytopenia: a cold autoantibody against platelet glycoprotein GP IIbH H van Vliet, M C Kappers-Klunne, J Abels
Thrombosis Research|June 1, 1983
Thrombotic thrombocytopenic purpura and plasma thromboxane B2 levelsF J Zijlstra, H H van Vliet, J E Vincent
Seminars in Thrombosis and Hemostasis|January 1, 1997
Aspirin in essential thrombocythemia: status quo and quo vadisM Griesshammer, M Bangerter, H H van Vliet, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1984
Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and deliveryJ J Michiels, J Stibbe, E Vellenga, et al.
British Journal of Haematology|April 28, 2001
Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpuraA H Loof, H H van Vliet, M C Kappers-Klunne
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Netherlands Journal of Medicine|January 1, 1984
Hereditary antithrombin III deficiency and venous thrombosisJ J Michiels, H H Van Vliet
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Acquired von Willebrand disease in monoclonal gammapathies: effectiveness of high-dose intravenous gamma globulinJ J Michiels, H H van Vliet
Scandinavian Journal of Haematology|February 1, 1984
IgM and IgG platelet antibodies in a case of infectious mononucleosis and severe thrombocytopeniaM C Kappers-Klunne, H H van Vliet
Transfusion|October 26, 1999
Coagulation factor levels in solvent/detergent-treated plasmaF W Leebeek, M R Schipperus, H H van Vliet
Atherosclerosis|August 1, 1990
Coffee, caffeine and hemostasis: results from two randomized studiesA A Bak, H H van Vliet, D E Grobbee
British Journal of Haematology|March 1, 1986
Pseudothrombocytopenia: a cold autoantibody against platelet glycoprotein GP IIbH H van Vliet, M C Kappers-Klunne, J Abels
Thrombosis Research|June 1, 1983
Thrombotic thrombocytopenic purpura and plasma thromboxane B2 levelsF J Zijlstra, H H van Vliet, J E Vincent
Seminars in Thrombosis and Hemostasis|January 1, 1997
Aspirin in essential thrombocythemia: status quo and quo vadisM Griesshammer, M Bangerter, H H van Vliet, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1984
Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and deliveryJ J Michiels, J Stibbe, E Vellenga, et al.
British Journal of Haematology|April 28, 2001
Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpuraA H Loof, H H van Vliet, M C Kappers-Klunne
Pageof 5